Jiangxi Institute of Biological Products Inc. (HKG:6915)

Hong Kong · Delayed Price · Currency is HKD

6.80

+1.47 (27.58%)

Last updated: Jul 16, 2026, 3:59 PM HKT

-8.11% (1Y)

Market Cap	2.10B
Revenue (ttm)	261.96M +6.6%
Net Income	105.49M
EPS	0.39
Shares Out	308.38M
PE Ratio	17.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,116,000
Open	5.34
Previous Close	5.33
Day's Range	4.95 - 7.00
52-Week Range	3.95 - 10.75
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About HKG:6915

Jiangxi Institute of Biological Products Inc. manufactures and exports biological products including Tetanus Antitoxin and Veterinary Medicine. The company offers Antitoxin Formulations, Active Pharmaceutical Ingredients, Equine Byproducts, essential oils, and plant extracts. It serves businesses in China and international markets. The company was founded in 1969 and is based in Ji'an, China. Jiangxi Institute of Biological Products Inc. is a subsidiary of Shenzhen Qianhai Tianzheng Biotechnology Co., Ltd. [Read more]

Industry Pharmaceutical Preparations

Founded 1969

Employees 327

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6915

Full Company Profile

Financial Performance

In 2025, HKG:6915's revenue was 235.41 million, an increase of 6.64% compared to the previous year's 220.76 million. Earnings were 94.79 million, an increase of 26.16%.

Financial numbers in CNY Financial Statements